Norvir Antitrust Cases Survive Abbott's Bid To Dismiss
Four suits accusing Abbot Laboratories of illegally jacking up the price for its HIV drug Norvir will remain intact now that a judge has rejected Abbott's motion arguing that the plaintiffs'...To view the full article, register now.
Already a subscriber? Click here to view full article